MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202621107600 A) filed by Dr. Aishwarya Narendra Kapse on September 08, 2026, for Modular Point-Of-Care Electrochemical Diagnostic System With A Replaceable Sensing Cartridge, Reusable Analyzer And Smartphone-Based Result Interpretation.
Inventor includes Dr. Aishwarya Narendra Kapse.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention relates to a modular point-of-care electrochemical diagnostic system for detecting Dengue Virus Non-Structural Protein 1 (NS1) antigen in a whole-blood sample (201). The system comprises a replaceable disposable sensing cartridge (110), a reusable portable electrochemical analyser (206), and a smartphone-based processing arrangement (107). The sensing cartridge comprises a Copper-assisted Graphite-Carbon-Silver Screen-Printed Electrode (CGCS-SPE) (110) and an MF1 membrane (205) for receiving a finger-prick whole-blood sample, separating cellular components, and directing the separated liquid fraction toward an antibody-functionalized sensing region. The analyser (206) interfaces with the cartridge and acquires an electrochemical response using Differential Pulse Voltammetry (DPV) (301). The response is processed by a smartphone application (107) for calibration-based determination of Dengue NS1 concentration and test- validity assessment, with results digitally displayed, stored, transmitted, or reported. The arrangement separates single-use sample-contacting components from reusable measurement electronics.
Disclaimer: Curated by HT Syndication.
